Back

A greater number of guideline-directed medical therapy was associated with improvement of the prognosis after mitral transcatheter edge-to-edge repair - insight from OCEAN-Mitral Registry-

1 September 2025 (09:54 - 10:06)
Organised by: Logo
Congress Presentation Part of: Strategies for better outcomes in heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ayano Yoshida

Kindai University, Osaka (Japan)

4 More presentations in this session

Presentation thumbnail
Determinants of attendance in cardiac rehabilitation among patients with myocardial infarction with and without heart failure
Doctor D. Brudasca (Angelholm, SE)
Abstract Slides Video
Presentation thumbnail
WATCH HF Awareness of prevalence, diagnosis and treatment of chronic heart failure in at risk patients in german primary care analysing real world data of chronic HF management in Germany
Associate Professor S. Wassmann (Munich, DE)
Abstract Slides Video
Presentation thumbnail
TELESAT-HF study: reduction of all-cause mortality in heart failure patients with a previous hospitalization in a real life study using a patient centered remote monitoring device
Professor N. Girerd (Nancy, FR)
Abstract Slides Video
Presentation thumbnail
Hemodynamic Changes in response to GLP-1 RA treatment in ICD and CRT patients: Insights from HeartLogic Sensor Data
Doctor F. Fussing (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Strategies for better outcomes in heart failure
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 09:54 CET
You may be interested in
thumbnail
Congress Presentation
Heart failure medical therapy and outcomes in patients undergoing transcatheter mitral valve repair for secondary mitral regurgitation: a TVT Registry analysis across 449 US centers
thumbnail
Congress Presentation
Impact of the guideline-directed medical therapy on the eligibility of patients for mitral valve transcatheter edge-to-edge repair in HFrEF
thumbnail
Congress Presentation
TEER plus medical therapy vs medical therapy alone for symptomatic moderate-to-severe functional mitral regurgitation: a comprehensive, up-to-date meta-analysis of randomized trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources